Prevention measures and exploratory pharmacological treatments of celiac disease. (Q34623902)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20877349 AND SRC:MED&resulttype=core&format=json

14 February 2020

review article

0 references

title

Prevention measures and exploratory pharmacological treatments of celiac disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20877349 AND SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20877349 AND SRC:MED&resulttype=core&format=json

14 February 2020

3

Elena F Verdu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20877349 AND SRC:MED&resulttype=core&format=json

14 February 2020

author name string

Maud Pinier

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20877349 AND SRC:MED&resulttype=core&format=json

14 February 2020

Jean-Christophe Leroux

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20877349 AND SRC:MED&resulttype=core&format=json

14 February 2020

language of work or name

English

0 references

publication date

28 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20877349 AND SRC:MED&resulttype=core&format=json

The American Journal of Gastroenterology

14 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20877349 AND SRC:MED&resulttype=core&format=json

14 February 2020

volume

105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20877349 AND SRC:MED&resulttype=core&format=json

14 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20877349 AND SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

2551-61; quiz 2562

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20877349 AND SRC:MED&resulttype=core&format=json

Coeliac disease: dissecting a complex inflammatory disorder

14 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

The spectrum of celiac disease: epidemiology, clinical aspects and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Increased prevalence and mortality in undiagnosed celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Effect of breast feeding on risk of coeliac disease: a systematic review and meta-analysis of observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Risk of celiac disease autoimmunity and timing of gluten introduction in the diet of infants at increased risk of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Rotavirus infection frequency and risk of celiac disease autoimmunity in early childhood: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

In celiac disease, a subset of autoantibodies against transglutaminase binds toll-like receptor 4 and induces activation of monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Small-intestinal histopathology and mortality risk in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Intestinal T-cell responses to high-molecular-weight glutenins in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Clinical staging and survival in refractory celiac disease: a single center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Etiology of nonresponsive celiac disease: results of a systematic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Etiologies and predictors of diagnosis in nonresponsive celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Association of celiac disease and intestinal lymphomas and other cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Newly identified genetic risk variants for celiac disease related to the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Shared and distinct genetic variants in type 1 diabetes and celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Mortality in celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Structural basis for gluten intolerance in celiac sprue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Identification of tissue transglutaminase as the autoantigen of celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Celiac disease: from pathogenesis to novel therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Future therapeutic options for celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Gliadin as a stimulator of innate responses in celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Breastfeeding: maintaining an irreplaceable immunological resource

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Lactobacillus paracasei normalizes muscle hypercontractility in a murine model of postinfective gut dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Prevalence of celiac disease: before and after a national change in feeding recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Complementary feeding: a commentary by the ESPGHAN Committee on Nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

The impact of probiotic on gut health

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Transglutaminases in inflammation and fibrosis of the gastrointestinal tract and the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Anti-transglutaminase antibodies in non-coeliac children suffering from infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Children born in the summer have increased risk for coeliac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Celiac disease and non-organ-specific autoantibodies in patients with chronic hepatitis C virus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Clinical onset of celiac disease after an episode of Campylobacter jejuni enteritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Patient perceptions of the burden of coeliac disease and its treatment in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Advances in celiac disease and gluten-free diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Systematic review: tolerable amount of gluten for people with coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Economic burden of a gluten-free diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Development of fibre-enriched gluten-free bread: a response surface methodology study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Effects of a gluten-free diet on gut microbiota and immune function in healthy adult human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Nutritional deficiencies in children on restricted diets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Can oats be taken in a gluten-free diet? A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

A Comparison of Diets with and without Oats in Adults with Celiac Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

No harm from five year ingestion of oats in coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Removing celiac disease-related gluten proteins from bread wheat while retaining technological properties: a study with Chinese Spring deletion lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Sourdough bread made from wheat and nontoxic flours and started with selected lactobacilli is tolerated in celiac sprue patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Pasta made from durum wheat semolina fermented with selected lactobacilli as a tool for a potential decrease of the gluten intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Limited efficiency of prolyl-endopeptidase in the detoxification of gliadin peptides in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Comparative biochemical analysis of three bacterial prolyl endopeptidases: implications for coeliac sprue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Protein engineering of improved prolyl endopeptidases for celiac sprue therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Heterologous expression, purification, refolding, and structural-functional characterization of EP-B2, a self-activating barley cysteine endoprotease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

The effects of ALV003 pre-digestion of gluten on immune response and symptoms in celiac disease in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Fermentation, purification, formulation, and pharmacological evaluation of a prolyl endopeptidase from Myxococcus xanthus: implications for Celiac Sprue therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Polymeric binders suppress gliadin-induced toxicity in the intestinal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Interaction of alpha-gliadin with poly(HEMA-co-SS): structural characterization and biological implication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Sevelamer, a phosphate-binding polymer, is a non-absorbed compound

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Physiological, pathological, and therapeutic implications of zonulin-mediated intestinal barrier modulation: living life on the edge of the wall

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Gliadin, zonulin and gut permeability: Effects on celiac and non-celiac intestinal mucosa and intestinal cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Mechanisms of epithelial translocation of the alpha(2)-gliadin-33mer in coeliac sprue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Transglutaminases: nature's biological glues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Transglutaminase 2 inhibitors and their therapeutic role in disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Structure-activity relationship analysis of the selective inhibition of transglutaminase 2 by dihydroisoxazoles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Reversible and competitive cinnamoyl triazole inhibitors of tissue transglutaminase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Structure-based design of alpha-amido aldehyde containing gluten peptide analogues as modulators of HLA-DQ2 and transglutaminase 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Antigen presentation in celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Inhibition of HLA-DQ2-mediated antigen presentation by analogues of a high affinity 33-residue peptide from alpha2-gliadin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Peptidomimetic compounds that inhibit antigen presentation by autoimmune disease-associated class II major histocompatibility molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

A small peptide from durum wheat gliadin prevents cell agglutination induced by prolamin-peptides toxic in coeliac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Induction of antigen-specific tolerance by oral administration of Lactococcus lactis delivered immunodominant DQ8-restricted gliadin peptide in sensitized nonobese diabetic Abo Dq8 transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Intranasal administration of a recombinant alpha-gliadin down-regulates the immune response to wheat gliadin in DQ8 transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Helminths and the IBD hygiene hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

The possible link between de-worming and the emergence of immunological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

A proof of concept study establishing Necator americanus in Crohn's patients and reservoir donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Targeting interleukin-15 in patients with rheumatoid arthritis: a proof-of-concept study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Recombinant human interleukin 10 suppresses gliadin dependent T cell activation in ex vivo cultured coeliac intestinal mucosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Alpha4-integrin antagonism--an effective approach for the treatment of inflammatory diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Cytosolic PLA2 is required for CTL-mediated immunopathology of celiac disease via NKG2D and IL-15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

R-spondin1, a novel intestinotrophic mitogen, ameliorates experimental colitis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Between celiac disease and irritable bowel syndrome: the "no man's land" of gluten sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Effect of pretreatment of food gluten with prolyl endopeptidase on gluten-induced malabsorption in celiac sprue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Potent transglutaminase inhibitors, aryl beta-aminoethyl ketones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Characterization of cereal toxicity for celiac disease patients based on protein homology in grains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Celiac disease: pathogenesis of a model immunogenetic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

Mapping of gluten T-cell epitopes in the bread wheat ancestors: implications for celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372

A food-grade enzyme preparation with modest gluten detoxification properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/AJG.2010.372